Contact this trialFirst, we need to learn more about you.
ACP-204 for Alzheimer's Disease
Recruiting2 awardsPhase 3
Costa Mesa, California
This trial is a 52-week study that aims to assess the safety and tolerability of ACP-204 in individuals with ADP over a longer period of time.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service